Hertility launches GYN-AI™- the world’s first clinical-grade, patent pending, AI tool trained exclusively on women’s health data

Hertility today announces the launch of GYN-AI™, a patent-pending, clinical-grade diagnostic tool set to redefine how fertility and gynaecological conditions are detected and diagnosed.

A moment of justice for women’s health

For decades, women have faced unacceptable delays in receiving diagnoses for gynaecological and fertility-related conditions, waiting years, sometimes decades, for answers that should take days.  Hertility’s GYN-AI™ changes that.

Hertility was founded to deliver personalised, and expert healthcare across every stage of a woman’s hormonal lifespan using a preventative and data-first approach. Now, that mission reaches a breakthrough moment with the launch of GYN-AI™, a first-of-its-kind, patent-pending diagnostic tool that redefines how fertility and gynaecological conditions are detected and diagnosed.

Developed by Hertility’s team of leading scientists, clinicians, and data engineers, GYN-AI™ combines years of research, clinical expertise, and advanced machine learning. Trained on Hertility’s uniquely comprehensive dataset,  including over one million Hertility Health Assessments and hundreds of thousands of blood results, the model achieves 98–99% diagnostic precision across 18 fertility-related and gynaecological conditions.

When tested against clinicians, GYN-AI™ performs as well as or outperforms them in diagnostic accuracy, reducing diagnosis times for some conditions from nine years to just seven days.

Closing the data gap and the gender health gap

Until now, healthcare data has been dangerously incomplete. Women were largely excluded from clinical trials until the 1990s, meaning much of modern medicine, and the data used to train most AI systems, reflects a male default. This makes even the most advanced AI models, including tools like ChatGPT, unreliable and potentially unsafe for women’s health.

GYN-AI™, by contrast, is built on Hertility’s own curated dataset: one of the largest and most clinically validated in women’s health, spanning over a million assessments and hundreds of thousands of blood test results linked to confirmed clinical outcomes. Built for women and from women’s data, it delivers a level of diagnostic precision and safety that is truly world-changing.

End-to-end care, powered by data and compassion

GYN-AI™ integrates seamlessly with Hertility’s full-service clinical pathway, offering end-to-end care from screening, diagnostic blood testing, and ultrasound scanning to telemedicine, prescriptions, IVF, and egg freezing.

This means women can move from assessment to diagnosis to treatment without delay, closing the loop on women’s healthcare like never before.

Dr Helen O’Neill, Founder and CEO of Hertility, said:

“I see this as a movement; and perhaps a moment of justice for women’s health. For too long, women have been dismissed, misdiagnosed, and left waiting years for answers about their own bodies. With GYN-AI™, we are changing that forever.

Every algorithm has been trained on the lived experiences, symptoms, and data of over a million women: women who deserved faster care, earlier intervention, and to be believed. This tool will help clinicians deliver answers in days, not years, giving women back their time, their control, and in some cases, their chance to create life.

This marks the beginning of a new era, one where women’s health is finally powered by data, intelligence, and compassion.”

Mr Srdjan Saso, Consultant Gynaecologist at Hertility, added:

“As a clinician, I have seen the damage that diagnostic delays cause physically, emotionally, and financially. GYN-AI™ is truly revolutionary in medicine- it allows us to detect potential issues earlier and with greater precision than ever before, guiding women to the right care pathway faster.

This technology does not replace doctors; it empowers them. It gives us a clinical tool built on real-world data that helps us treat women sooner, more accurately, and more holistically.”

The beginning of a new clinical paradigm

GYN-AI™ represents a seismic shift from reactive to proactive care, bridging science, compassion, and intelligence to transform how women are diagnosed and treated.

Hertility’s mission is clear: to close the gender health gap by delivering faster, data-driven, and personalised diagnostic care that gives women the answers they deserve.

We are not just advancing technology. We are transforming lives and creating them.

To begin your own journey toward better understanding your hormones and reproductive health, start your Hertility Health Assessment today at www.hertilityhealth.com.